The three electrophoretic variants of phosphoglucomutase in Saccharomyces cerevisiae breeding stocks are produced by two unlinked genes, pgm-1 and pgm-2; pgm-l contains two known alleles, pgm-la and pgm-lb, each of which specifies a minor phosphoglucomutase component, and pgm-2 specifies the major phosphoglucomutase component.
The initial steps by which galactose is converted to glucose-6-phosphate in Saccharomyces cerevisiae are catalyzed by the three inducible enzymes, galactokinase, galactose-1-phosphate uridyl transferase, and uridine diphosphogalactose-4-epimerase, and the constitutive enzyme phosphoglucomutase. One of the classes of galactose-negative (Gal-) mutants in S. cerevisiae is characterized by normal levels of the three inducible galactose enzymes and reduced levels (10 to 20% of normal) of phosphoglucomutase. The mutations responsible for this phenotype map in the ga-5 locus and their only phenotypic expression appears to be upon the metabolism of galactose (2) .
An examination of Gal+ stocks of S. cerevisiae showed that they contained two electrophoretically and chromatographically distinct forms of phosphoglucomutase: a major form which constituted 80 to 90% of the phosphoglucomutase activity and a minor form which made up the remainder of the activity. The major form was either absent or present in sharply reduced amounts in ga-5 mutants, but the minor form was not affected (9) . It was presumed that the two forms of phosphoglucomutase were under the control of separate genes, but the lack of mutations affecting the minor component made it impossible to prove this.
We will show in this paper that the major and minor forms of phosphoglucomutase in S. cerevisiae are in fact controlled by two nonallelic genes, and that the locus controlling the minor form contains two alleles which specify enzymes of different electrophoretic mobility.
MATERIALS AND METHODS
Cultures were grown in a fluid medium containing 2% Bacto Peptone (Difco), 1% Yeast Hydrolysate (Fleischmann) , and 2% glucose in tap water. After 24 hr of incubation with shaking at 30 C, the stationary-phase cells were harvested by centrifugation and washed once with distilled water. The packed cells were then suspended in an equal volume of distilled water and passed through a French pressure cell at 14,000 psi to yield extracts which were clarified by centrifugation.
The electrophoresis bridge buffer was 0.05 M maleic acid, electrometrically titrated to pH 6.3 with freshly prepared KOH. Starch gels, containing 12% starch (Starch-Hydrolysed, Connaught Medical Research Laboratories) in 450 ml of a 1:10 dilution of the bridge buffer, were prepared according to Smithies (7) . The gel mold measured 300 by 124 by 7 mm (inside dimensions), with provisions for five sample wells located in the center. Samples of clarified extracts containing 15 to 20 mg of protein were absorbed in filter paper tabs cut to well size from 0.5-inch (1.25 cm) antibiotic assay discs and were inserted into the gel after it had equilibrated at 4 C. Horizontal electrophoresis was conducted at 4 C for 18 hr at 140 v with an operating current of 15 to 25 ma. After electrophoresis, the gel was removed from the mold and sliced in the horizontal plane to yield two slabs for staining.
The stain used for revealing phosphoglucomutase activity on the starch gels was prepared as follows. Difco Nobel agar (250 mg) was melted in 13 ml of distilled water. To this was added 0.2 ml of 0.1 M MgSO4 and 7.5 ml of 0.05 M L-histidine (pH 8.1), and the mixture was allowed to cool to 45 C. The following were then added in order: 0.5 ml of 0.1 M glucose-lphosphate (Nutritional Biochemicals Corp., Cleveland, Ohio), 0.15 ml of 0.05 M nicotinamide adenine dinucleotide phosphate (Sigma Chemical Co., St. Louis, Mo.), 2.0 ml of 0.5% MTT tetrazolium (Sigma), 0.5 ml of 0.8% phenazine methosulfate (Sigma), 5 Aliters of glucose-6-phosphate dehydrogenase (Sigma; 180 units/ml), and 5 jsliters of 6-phosphogluconate dehydrogenase (Sigma; 200 units ml). The resulting stain solution was poured over the freshly cut surface of the starch gel, which was then on October 22, 2017 by guest http://jb.asm.org/ Downloaded from PHOSPHOGLUCOMUTASE IN YEAST incubated in the dark at 37 C for 1.5 to 2 hr. Areas with phosphoglucomutase activity were stained a dark purple color, and no color developed if the glucose-lphosphate was omitted. The addition of glucose diphosphate did not enhance color development; it was apparently present in adequate amounts as a contaminant in the glucose-i-phosphate.
Conventional methods for yeast genetics were used (3) . RESULTS A survey of our breeding stocks revealed that some of the segregants from a cross of a ga-S mutant with a wild type possessed a new minor phosphoglucomutase component whose electrophoretic mobility was intermediate between those of the two components observed by Tsoi and Douglas (9) . This is illustrated in Fig. 1-3 , in which the three components are numbered PGM-la, PGM-lb, and PGM-2 in order of their decreasing electrophoretic mobility toward the cathode. PGM-2 is the major component, and PGM-la and PGM-lb are the minor components.
To test linkage between the loci controlling PGM-la and PGM-lb, segregants were examined from a diploid prepared by mating a haploid containing only PGM-la with a haploid containing only PGM-lb. The diploid (strain 304) and the segregants from 10 complete tetrads and 2 tetrads in which only three segregants were viable were tested for the presence of PGM-la and PGM-lb by electrophoresis of cell extracts. The diploid was Gal-and synthesized both enzymes, and the segregants, all of which were Gal-, contained either PGM-la or PGM-lb (Fig. 1) . In the segregants from the 10 complete tetrads, each tetrad yielded two segregants that contained PGM-la and two that contained PGM-lb.
The fact that no recombinants were observed in the segregants from diploid 304 suggested that the loci controlling PGM-la and PGM-lb were closely linked or allelic. However, as phosphoglucomutase is a vital enzyme, an alternative explanation for the failure to observe recombinants was also possible. This was that the loci were unlinked and that recombinant ascospores which lacked both enzymes would not be viable. This would result in the formation of a substantial number of asci containing one or two nonviable ascospores.
The high viability of the ascospores (98 % in 20 asci) produced by diploid 304 made this explanation seem unlikely. Furthermore, in the two tetrads each producing only three viable segregants, no recombinants were found which contained both PGM-la and PGM-lb.
To obviate the question of segregant viability in diploid 304, a second cross was made between a haploid containing PGM-2 and PGM-lb and a haploid containing PGM-2 and PGM-la. The diploid synthesized all three enzymes, and an examination of 13 tetrads from this cross showed that only parental di-type asci were produced (Fig. 2) . The results of this and the previous cross thus indicate that the loci controlling the synthesis of PGM-la and PGM-lb are either allelic or very closely linked.
To determine whether the gene controlling PGM-2 was linked to the genes controlling PGM-la and PGM-lb, a diploid was prepared in which one parent contained PGM-la and the other parent contained PGM-lb and PGM-2. The analysis of 10 tetrads from this cross revealed that nine of the asci were of the tetra-type class (Fig.  3) and one was of the nonparental di-type class. Thus, no linkage was detected between the locus controlling PGM-2 and the alleles controlling PGM-la and PGM-lb.
PGM-la and PGM-2 differ in their elution profiles from a column of carboxymethyl cellulose, since PGM-la elutes in the column break-(-) C-) through volume (9) . When an extract of haploid 195-2D which contained only PGM-lb was chromatographed in the same manner, the phosphoglucomutase activity was found exclusively in the column breakthrough volume.
DISCUSSION
Phosphoglucomutase has been shown to exist in multiple forms in many eucaryotic organisms. In man, seven electrophoretic variants have been detected in red cell hemolysates by starch gel electrophoresis, and a role for at least two structural genes has been suggested to account for the patterns of inheritance observed (4, 8) . By fractionating cell extracts by column chromatography, Joshi et al. (5) showed that phosphoglucomutase exists in two forms, PGM I and PGM II, in a variety of organisms of diverse phyletic origin, including man and bakers' yeast. The two forms of phosphoglucomutase from human and rabbit muscle and yeast possessed the same molecular weights, and both forms of the rabbit muscle enzyme appeared to be single polypeptide chains without an N terminus. Joshi et al. (5) suggested that PGM I and PGM II may be the products of two homologous genes which arose by the process of gene duplication (6) , and, although the loci have been extensively modified by independent mutations during evolution, they still specify proteins with phosphoglucomutase activity.
PGM I and PGM II described by Joshi et al. (5) in bakers' yeast are probably the same as the minor and major components, respectively, that we observed in S. cerevisiae (9) . The second minor component (PGM-lb) described in this paper would be classified as another variety of PGM I, since it elutes in the breakthrough volume of a carboxymethyl cellulose column.
The three electrophoretic variants of phosphoglucomutase in breeding stocks of S. cerevisiae can be accounted for by the activity of two unlinked genes. One locus, ga-S, specifies the major component; mutations in this locus result either in the absence of this component from cell extracts or in its presence in sharply reduced amounts. Such mutants can be recognized by their inability to utilize galactose as a source of energy. The second phosphoglucomutase locus consists of two alleles, based on the criterion that recombination between them has not been found. Each allele specifies a minor phosphoglucomutase component. Mutations which block the synthesis of the minor components have not been detected. A mutation that lowers the activity of phosphoglucomutase in Neurospora crassa to a few per cent of normal levels has been described by Brody and Tatum (1) . According to these workers, there is no evidence for multiple forms of phosphoglucomutase in N. crassa, and the mutation is interpreted as one which affects the primary structure of the enzyme.
There is some evidence from our work that the different forms of phosphoglucomutase in yeast have different functions which might be of adaptive significance to the cell. The major form appears to be required for galactose utilization, but either one of the minor forms becomes sufficient for this purpose in the presence of a suppressor mutation which does not alter the level of activity of phosphoglucomutase in cell extracts (Bevan and Douglas, unpublished data). It is clear from this that there are qualitative functional differences in the phosphoglucomutases of S. cerevisiae, but additional study will be required to determine the nature of these differences. Now that more than one locus is known to be concerned in phosphoglucomutase synthesis in S. cerevisiae, it seems appropriate to apply a uniform terminology to designate the genes involved. We propose that the ga-5 locus, which was named before its control of the major phosphoglucomutase component was known, be redesignated as pgm-2. We propose the designation pgm-1 for the second phosphoglucomutase locus, with the allele specifying the minor component of intermediate electrophoretic mobility designated as pgm-lb and the allele specifying the minor component of greater electrophoretic mobility designated as pgm-la.
